CHM chimeric therapeutics limited

Ann: Successful completion of Institutional Entitlement Offer, page-10

  1. 4,663 Posts.
    lightbulb Created with Sketch. 2153
    "New Shares issued under the Institutional Entitlement Offer are expected to be issued on 1 March
    2022. New Options issued under the Institutional Entitlement Offer will be issued together with
    New Shares and Options to be issued under the Retail Entitlement Offer on 18 March 2022 (subject
    to Institutional Shareholders holding at least the number of New Shares they subscribed for under
    the Institutional Entitlement Offer)"

    A clever way of preventing instos dumping their new shares on market while retail are having their go.
    That's a very personal decision to make. You may be able to buy a head on market for 16c plus brokerage, and that seems a great price. The alternative is buy a head and an option for 17c with no brokerage. The option is tradable on market after it is issued. So if you sell it you reduce your 17c purchase price. If you keep it and the third and fourth cohorts show statistically significant results and the price goes up (for example), you have more exposure and the option of selling them at a higher price or converting them in a few years. Upside to both ways, only you know what risk profile you prefer.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.